REGENXBIO

step up climb ladder sky hang on rung
Biotech

Regenxbio gene therapy passes interim test as pivotal data loom

Regenxbio has guided its DMD gene therapy candidate through another test, reporting a clean safety profile and functional improvements.
Nick Paul Taylor Mar 12, 2026 5:49am
stack of letters mail envelopes

FDA details Regenxbio rare disease rejection

Mar 3, 2026 12:56pm
Image of a neon sign with the word no lit up next to an unlit yes

FDA rejects Regenxbio's Hunter syndrome gene therapy

Feb 9, 2026 4:05pm
Make a delay and accumulation of outstanding tasks Full stop

Brain tumor prompts FDA hold for 2 Regenxbio gene therapies

Jan 28, 2026 9:42am
clock delay wait time alarm

Regenxbio's Hunter gene therapy latest to face FDA delay

Aug 19, 2025 10:30am
An artists depiction of DNA molecules made up of tiny particles

RegenXBio links DMD gene therapy to improved outcomes

Jun 5, 2025 8:52am